ArticleThe Journal of biological chemistry2016

A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses.

Bai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.